[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"aphthus-ulcer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:aphthus-ulcer":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":20,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100586069",false,"NCT06910579","Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers","Efficacy of Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers: A Randomized Controlled Clinical Trial","Inclusion Criteria:\n\n* Clinically diagnosed patients with chronic aphthous stomatitis measuring ≤6 mm in size in the oral cavity and who gave written consent for participation.\n* Only single ulcers were considered for the study.\n* Systemically healthy patients.\n\nExclusion Criteria:\n\n* The study excluded patients with a history of associated systemic disease.\n* Cases of chronic aphthous stomatitis (major), lesions of herpetic form, numerous aphthae, and smoking.\n* Patients with a history of hypersensitivity to the used agents.\n* Pregnancy and lactation","ALL",{"count":17,"type":18},30,"ESTIMATED","INTERVENTIONAL",[21,22],"PHASE2","PHASE3","Interventions of both groups:\n\nOxygenated gel Group: 15 patients who used oxygenated gel (Blue®m, Wijhe, Netherlands) were trained by the co-investigator (A.H) through real demonstration for topical application of the gel on aphthous ulcers, which entails the application of 1-2 ml of oxygenated gel directly to the ulcer two times per day and this was repeated for 7 days.\n\nTriamcinolone acetonide Group: 15 patients were treated with Kenalog in orabase (Triamcinolone acetonide 0.1% oral paste 5g), four times (i.e., at 8 am, 12 noon, 4 pm, and 8 pm) a day for 7 days at intervention group.\n\nPatients in both groups were reexamined after treatment at different intervals (day 3, day 5, day 7, and day 10).",[25],"Aphthus Ulcer","RECRUITING","2025-09-16",{"date":29,"type":30},"2025-09-18","ACTUAL",{"date":32,"type":30},"2025-03-15",{"date":34,"type":18},"2026-04-12",{"name":36,"class":37},"British University In Egypt","OTHER",""]